Canaccord Genuity Maintains a 'Buy' on Edwards Lifesciences (EW); Voting in Favor of SAPIEN
Tweet Send to a FriendGet Alerts EW Hot Sheet
Price: $65.53 -0.29%
Rating Summary:
11 Buy, 14 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Rating Summary:
11 Buy, 14 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Trade EW Now!
Canaccord Genuity maintains a 'Buy' on Edwards Lifesciences (NYSE: EW) price target of $103.00.
Analyst, Jason R. Mills, said, "The FDA panel voted in favor of SAPIEN, intimating that Cohort A data provided reasonable assurance of the safety, effectiveness and benefits outweighing risks of SAPIEN TAVI in high-risk patients with severe symptomatic aortic stenosis. We currently expect formal FDA approval in late Q3/early Q4, but think earlier-than-expected approval is possible, which could portend upside to our/consensus revenue/EPS estimates."
For an analyst ratings summary and ratings history on Edwards Lifesciences click here. For more ratings news on Edwards Lifesciences click here.
Shares of Edwards Lifesciences closed at $90.54 yesterday, with a 52 week range of $61.59-$92.30.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Jason R. Mills, said, "The FDA panel voted in favor of SAPIEN, intimating that Cohort A data provided reasonable assurance of the safety, effectiveness and benefits outweighing risks of SAPIEN TAVI in high-risk patients with severe symptomatic aortic stenosis. We currently expect formal FDA approval in late Q3/early Q4, but think earlier-than-expected approval is possible, which could portend upside to our/consensus revenue/EPS estimates."
For an analyst ratings summary and ratings history on Edwards Lifesciences click here. For more ratings news on Edwards Lifesciences click here.
Shares of Edwards Lifesciences closed at $90.54 yesterday, with a 52 week range of $61.59-$92.30.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Janney Capital Trims Numbers on Buckle (BKE), Margins Peaking
- Jefferies Lifts Numbers on Diana Shipping (DSX) Post Q1
- Toll Bros. (TOL) Estimates/PT Raised at Compass Point
Create E-mail Alert Related Categories
Analyst Comments
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
